This company has been acquired
SeaSpine Holdings (SPNE) Stock Overview
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
SPNE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
SeaSpine Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.54 |
| 52 Week High | US$13.64 |
| 52 Week Low | US$5.48 |
| Beta | 1.3 |
| 1 Month Change | 34.56% |
| 3 Month Change | 73.14% |
| 1 Year Change | -24.59% |
| 3 Year Change | -36.57% |
| 5 Year Change | -6.65% |
| Change since IPO | -54.57% |
Recent News & Updates
SeaSpine Holdings (NASDAQ:SPNE) Has Debt But No Earnings; Should You Worry?
Sep 24
SeaSpine: Bottom Line Fundamentals Continue To Soften
Sep 22Recent updates
SeaSpine Holdings (NASDAQ:SPNE) Has Debt But No Earnings; Should You Worry?
Sep 24SeaSpine: Bottom Line Fundamentals Continue To Soften
Sep 22SeaSpine amends $30M credit facility
Jul 19SeaSpine: Lacks Equity Premium To Deliver Real Risk-Adjusted Return
Jul 08Is SeaSpine Holdings (NASDAQ:SPNE) Using Debt Sensibly?
Jun 07It Looks Like The CEO Of SeaSpine Holdings Corporation (NASDAQ:SPNE) May Be Underpaid Compared To Peers
May 27Did SeaSpine Holdings' (NASDAQ:SPNE) Share Price Deserve to Gain 61%?
Dec 07Shareholder Returns
| SPNE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 14.3% | -3.0% | -0.9% |
| 1Y | -24.6% | -0.3% | 20.1% |
Return vs Industry: SPNE underperformed the US Medical Equipment industry which returned -17.9% over the past year.
Return vs Market: SPNE underperformed the US Market which returned -21.5% over the past year.
Price Volatility
| SPNE volatility | |
|---|---|
| SPNE Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SPNE's share price has been volatile over the past 3 months.
Volatility Over Time: SPNE's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 523 | Keith Valentine | www.seaspine.com |
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company’s orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.
SeaSpine Holdings Corporation Fundamentals Summary
| SPNE fundamental statistics | |
|---|---|
| Market cap | US$360.18m |
| Earnings (TTM) | -US$64.84m |
| Revenue (TTM) | US$229.75m |
Is SPNE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SPNE income statement (TTM) | |
|---|---|
| Revenue | US$229.75m |
| Cost of Revenue | US$87.83m |
| Gross Profit | US$141.92m |
| Other Expenses | US$206.75m |
| Earnings | -US$64.84m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.72 |
| Gross Margin | 61.77% |
| Net Profit Margin | -28.22% |
| Debt/Equity Ratio | 9.4% |
How did SPNE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/01/06 14:05 |
| End of Day Share Price | 2023/01/04 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SeaSpine Holdings Corporation is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Kyle Rose | Canaccord Genuity |
| Brandon Folkes | Cantor Fitzgerald & Co. |